Results

Total Results: 2,065 records

Showing results for "years".

241. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update--Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
     January 01, 2018 - other conditions (mean 11.34, range 4-19 years). … The average age of patients was 12.8 years. … adolescents, the age of participants was typically below 12 years and close to 9-10 years (no study … had a mean age below 8 years). … Nor was the mean age in any condition below 8 years.

242. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
     January 01, 2015 - In 2014, nearly 4 years after initiation of the horizon scanning system, AHRQ requested some exploratory … For example, we used data on the retail cost of new targeted oncology drugs over the past 4 years as … In more than 4 years of tracking in the horizon scanning system, the intervention has diffused from … , compared to Iluvien which is intended to last up to 3 years. … Children with Morquio A syndrome are typically identified by 5 years of age and are often insured.

243. Title (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/obesity-child_research-protocol.pdf
     March 31, 2010 - Nutrition Examination Survey indicated approximately 17% of US children and adolescents (ages 2-19) years … are obese. 2 Obesity prevalence increased from 5% to 10.4% (children aged 2-5 years); 6.5% to 19.6% … (children aged 6-11 years); and 5% to 18.1% (adolescents aged 12-19 years) between 1976-1980 and 2007 … Population(s)  All children between the ages of 2 and 18 years old, regardless of BMI classification … The time points of interest for outcome changes are: 1 year, 2 years, 3 years and more than 3 years

244. PKU Surveillance Assessment_CER 56_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
     January 15, 2013 - strategy employed for the original report, we conducted a limited literature search of Medline for the years … consistently lower than 605 µmol/L, was associated with lower child cognitive scores at 4 and 7 years … Efficacy and safety of BH4 before the age of 4 years in patients with mild phenylketonuria. … , range 1 month-46 years (26%< 6 yrs., 13% 6-11 years; 16% 12-18 yrs., 45% adults) Other characteristics … or older Exclusion criteria: pregnancy, age less than 4 years, any clinical contraindication to

245. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
     January 01, 2010 - neurodevelopmental disorders, with an estimated prevalence of 6.7 cases per 1,000 children aged 8 years … Including studies with participants older than 12 years if the mean age plus standard deviation is ≤ … 12 years. … Including studies with participants older than 12 years if the mean age plus standard deviation is ≤ … 12 years.

246. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
     December 09, 2009 - neurodevelopmental disorders, with an estimated prevalence of 6.7 cases per 1,000 children aged 8 years … Including studies with participants older than 12 years if the mean age plus standard deviation is ≤ … 12 years. … Including studies with participants older than 12 years if the mean age plus standard deviation is ≤ … 12 years.

247. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - system is intended to identify interventions that purport to address an unmet need and are up to 3 years … out on the horizon and then to follow them up to 2 years after initial entry into the health care … Topics eligible for inclusion are those interventions expected to be within 0–3 years of potential … their work on preliminary psychobiological studies, researchers have been investigating for a few years

248. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - system is intended to identify interventions that purport to address an unmet need and are up to 3 years … out on the horizon and then to follow them up to 2 years after initial entry into the health care … Topics eligible for inclusion are those interventions expected to be within 0–3 years of potential … Health grant to support a 15,000-patient clinical trial, whose outcomes we will monitor in the coming years

249. Treatments for Fecal Incontinence: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_clinician.pdf
     July 01, 2016 - Clinician Summary Archived: This report is greater than 3 years old. … Archived: This report is greater than 3 years old. … Archived: This report is greater than 3 years old. … No. 15(16)-EHC037-3-EF July 2016 www.ahrq.gov Archived: This report is greater than 3 years old.

250. Therapies for Children with Autism Spectrum Disorders (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_consumer.pdf
     September 01, 2014 - Yes, if: The child you care for is 0 to 12 years old and has autism spectrum disorder (ASD). … No, if: The child you care for is older than 12 years or has a different behavioral, emotional, developmental … research about the possible benefits and negative side effects of therapies for children who are 0 to 12 years … The programs can last as long as 12 weeks to 3 years.

251. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
     November 01, 2010 - malignancies is relatively robust, including randomized, controlled trials that date back 10 to 15 years … All Child: 0-18 years=3709 #107 Search #104 AND #106 17:44:42 9536 #106 Search "Humans"[Mesh] 17:29 … Study, Controlled Clinical Trial, Guideline, English, All Infant: birth-23 months, All Child: 0-18 years … Study, Controlled Clinical Trial, Guideline, English, All Infant: birth-23 months, All Child: 0-18 years … Study, Controlled Clinical Trial, Guideline, English, All Infant: birth-23 months, All Child: 0-18 years

252. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - disease remission 364 JIA, with clinical remission relapse rate in the 2 treatment groups 3 years … Partial responders were younger at onset (median 5.2 years vs 10.2 years; P=0.004). … 13 cases of IBD in JIA patients using etanercept were identified (362 per 100,000 patient-years, … Median time of onset was 6 years and 10 months. … Time between start of etanercept and IBD was 9 days to 4.5 years Author, year Trial n Subjects

253. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - disease remission 364 JIA, with clinical remission relapse rate in the 2 treatment groups 3 years … Partial responders were younger at onset (median 5.2 years vs 10.2 years; P=0.004). … 13 cases of IBD in JIA patients using etanercept were identified (362 per 100,000 patient-years, … Median time of onset was 6 years and 10 months. … Time between start of etanercept and IBD was 9 days to 4.5 years Author, year Trial n Subjects

254. Crohns-Disease Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
     February 01, 2014 - will have active disease at least once each year, 67 percent will fluctuate between years of active … The mean and median age at the time of randomization ranged from 26 to 47 years. … The minimum age reported in any one study was 14 years,26 and the maximum age was 78 years.27 Remission … The RR from one RCT with 2 years of followup was 1.0. … Population Characteristics The mean age of patients ranged from 12 to 14 years.

255. Topic 0614 Tonsillectomy NSD FINAL CC (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0768-141211.pdf
     October 23, 2014 - recurrent throat infections (at least 7 episodes in the past year, at least 5 episodes per year for 2 years … , or at least 3 episodes per year for 3 years) Intervention(s): Tonsillectomy Comparator(s): Prophylactic

256. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
     March 01, 2012 - (from 2 years). … Peer Reviewer 6 Executive Summary In FLEX, 5 years off was compared with 10 years on; those with … . however, after five years, this benefit-risk of BIS may reverse. … 5 years showed no additional benefit of continuing the additional 5 years in reducing the risks of … to 3 years.

257. Fagerlin-notes-151007 copy-Teresa (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/fagerlin-presentation.pdf
     May 29, 2025 - And if they said “Yes, in the last 2 years,” then we asked them  about their decision-­‐making experience … Now how many want to take a drug every day for 5 years to get that one percent difference? … People have been  arguing for years that we should  present information  using graphs. … huge increase in colorectal   cancer screening after Katie Couric got screened live on TV about 10 years … Another example is the mammography screening guidelines that came out 2 or 3 years ago and people were

258. Outcome Definition and Measurement in Observational Comparative Effectiveness Research
     effectivehealthcare.ahrq.gov/sites/default/files/outcome-definition-and-measurement-chapter-6.pptx
     January 01, 2013 - and disability-adjusted life years Economic and Utilization Outcomes Economic and Resource Outcomes … of life according to its quality and then to generate quality-adjusted life years (QALYs). … Disability-Adjusted Life Years Disability-adjusted life years are another measure of overall disease … burden expressed as the number of years lost to poor health, disability, or premature death. … Potential years of life lost to premature death are supplemented with years of healthy life lost due

259. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - which were documented in paper charts at the health maintenance organization (HMO) an average of 11 years … in incident users defined by one-year without an antidepressant medication (6.03 per 1,000 person years … design is that it may not allow evaluation of the long- term effects of drugs, such as cumulative years … Relatively few patients will have five or more years of continuous exposure to a drug, especially a … Moreover, many databases are limited in their ability to follow patients for five or more years because

260. Diabetes-Behavior-Programs Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
     June 05, 2014 - Disparities in prevalence, care, and outcomes Older adults (>65 years) are disproportionately affected … ] and their families, young adults [19-30 years], adults [31-64 years], older adults (≥65 years]); race … ], adults [31-64 years], older adults [≥65 years]); race or ethnicity; socioeconomic status (e.g., family … ) and their families • Young adults (19-30 years) • Adults (31-64 years of age) • Older adults … ; >5 to 10 years; and >10 years.